HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant, truncated B. circulans keratanase-II: Description and characterisation of a novel enzyme for use in measuring urinary keratan sulphate levels via LC-MS/MS in Morquio A syndrome.

AbstractOBJECTIVE:
Morquio A syndrome (mucopolysaccharidosis IVA; MPS IVA) is an autosomal recessive lysosomal storage disorder caused by deficient N-acetylgalactosamine-6-sulphatase (GALNS) activity. Early and accurate diagnosis of this condition is critical for improved patient outcomes, particularly as enzyme replacement therapy has recently become available. An LC-MS/MS assay utilising keratan sulphate (KS) disaccharides derived from keratanase-II digestion provides a sensitive and specific means for quantitation of urinary KS, a screening biomarker for Morquio A (Oguma et al., 2007; Martell et al., 2011). To ensure a reliable supply of keratanase-II, we sought to produce a Bacillus circulans-derived enzyme via a recombinant approach in Escherichia coli.
DESIGN AND METHODS:
Bioinformatics analysis of the B. circulans keratanase-II enzyme identified likely dispensable C-terminal domains amenable to enhancement via protein engineering. A truncated form of the enzyme was designed to remove the domains predicted to be unnecessary for catalytic activity and detrimental to recombinant expression in E. coli.
RESULTS:
C-terminally truncated, recombinant B. circulans keratanase-II was purified to >98% homogeneity and extensively characterised, demonstrating desired activity, specificity and utility in LC-MS-based quantitation of urinary KS from Morquio A and control samples, and is functionally indistinguishable from full-length, native B. circulans-derived keratanase-II.
CONCLUSIONS:
This novel, recombinant keratanase-II meets all performance requirements and can be produced in a rapid and reproducible manner. We speculate that other related bacterial enzymes of biomedical or industrial interest may be amenable to similar engineered enhancements.
AuthorsMichael Steward, Yana Berezovskaya, Huiyu Zhou, Renée Shediac, Cynthia Sun, Nicole Miller, Phillip M Rendle
JournalClinical biochemistry (Clin Biochem) Vol. 48 Issue 12 Pg. 796-802 (Aug 2015) ISSN: 1873-2933 [Electronic] United States
PMID25866399 (Publication Type: Journal Article)
CopyrightCopyright © 2015. Published by Elsevier Inc.
Chemical References
  • Biomarkers
  • Keratan Sulfate
  • keratanase II
  • Acetylglucosaminidase
Topics
  • Acetylglucosaminidase (biosynthesis, chemistry, genetics, metabolism)
  • Adolescent
  • Adult
  • Animals
  • Bacillus (enzymology, genetics)
  • Bioengineering (methods)
  • Biomarkers (urine)
  • Case-Control Studies
  • Catalysis
  • Cattle
  • Child
  • Child, Preschool
  • Chromatography, Liquid (methods)
  • Cloning, Molecular
  • Escherichia coli (enzymology, genetics)
  • Humans
  • Keratan Sulfate (urine)
  • Mucopolysaccharidosis IV (urine)
  • Protein Structure, Tertiary
  • Tandem Mass Spectrometry (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: